Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotypeGiulio Metro, Lucio Crinò, Rita Chiari et al.|Lung Cancer|2012Cited by 70
Incidence of Ct scan-detected pulmonary embolism in patients with oncogene-addicted, advanced lung adenocarcinomaMelina Verso, Giancarlo Agnelli, Rita Chiari et al.|Thrombosis Research|2015Cited by 49
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluationGiulio Metro, Lucio Crinò, Rita Chiari et al.|Cancer Chemotherapy and Pharmacology|2011Cited by 19
Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysisPatrizia Ciammella, Marcello Tiseo, Salvatore Cozzi et al.|Frontiers in Oncology|2024Cited by 3
Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Alessio Bruni, Paolo Borghetti, Vieri Scotti et al.|Current Oncology|2024Cited by 3